EMA: Financial regulation

This procedure concerns the financial rules and budgetary framework governing the European Medicines Agency (EMA). It ensures that the agency has the necessary funding and administrative oversight to regulate and monitor medicinal products across the European Union.

This affects the pharmaceutical industry and healthcare providers by ensuring the agency remains financially stable and transparent in its operations.